APA (7th ed.) Citation

Cady, R. K., Munjal, S., Cady, R. J., Manley, H. R., & Brand-Schieber, E. (2017). Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine. Journal of headache and pain, 18(1), 17-8. https://doi.org/10.1186/s10194-016-0717-7

Chicago Style (17th ed.) Citation

Cady, Roger K., Sagar Munjal, Ryan J. Cady, Heather R. Manley, and Elimor Brand-Schieber. "Randomized, Double-blind, Crossover Study Comparing DFN-11 Injection (3 mg Subcutaneous Sumatriptan) with 6 mg Subcutaneous Sumatriptan for the Treatment of Rapidly-escalating Attacks of Episodic Migraine." Journal of Headache and Pain 18, no. 1 (2017): 17-8. https://doi.org/10.1186/s10194-016-0717-7.

MLA (9th ed.) Citation

Cady, Roger K., et al. "Randomized, Double-blind, Crossover Study Comparing DFN-11 Injection (3 mg Subcutaneous Sumatriptan) with 6 mg Subcutaneous Sumatriptan for the Treatment of Rapidly-escalating Attacks of Episodic Migraine." Journal of Headache and Pain, vol. 18, no. 1, 2017, pp. 17-8, https://doi.org/10.1186/s10194-016-0717-7.